» Articles » PMID: 39165775

Simultaneous Vaccination Against Seasonal Influenza and COVID-19 Among the Target Population in Italy

Overview
Specialty Public Health
Date 2024 Aug 21
PMID 39165775
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Annual influenza and COVID-19 vaccinations are effective tools for reducing the disease burden. The goals of the present cross-sectional survey were to investigate attitudes and behaviors toward the simultaneous vaccination against seasonal influenza and COVID-19 and the factors associated.

Methods: Questionnaires were self-administered or researcher-administered between October 2023 and February 2024 in an immunization center in the southern part of Italy.

Results: All 151 subjects eligible for influenza and COVID-19 vaccinations who attended the center agreed to participate. A total of 59.9% of respondents received concurrent seasonal influenza and COVID-19 vaccinations. Those who perceived that the simultaneous vaccination was safer and those who have been infected by SARS-CoV-2 fewer times were more likely to have simultaneously received both vaccinations. Regarding the reasons reported, half of the sample stated that the simultaneous vaccination was safe and that they were adequately informed. This was more likely indicated by the respondents who had received at least four doses of the COVID-19 vaccination. Among those who had not received the simultaneous vaccination, 70.7% and 29.3% had received only seasonal influenza and COVID-19.

Conclusion: Educational health communication campaigns are necessary to improve compliance with simultaneous administration of seasonal influenza and COVID-19 vaccinations and to increase the unsatisfactory coverage.

References
1.
Domnich A, Grassi R, Fallani E, Ciccone R, Bruzzone B, Panatto D . Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey. J Pers Med. 2022; 12(2). PMC: 8878648. DOI: 10.3390/jpm12020139. View

2.
Choi M, Yu Y, Kim J, Ju H, Shin S, Yang Y . Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: implications of immune imprinting and interference. Clin Microbiol Infect. 2024; 30(5):653-659. DOI: 10.1016/j.cmi.2024.01.010. View

3.
Zhou Q, Tian T, Ni J, Zhao X, Li H, Yang Y . COVID-19 Vaccination Acceptance in China after It Becomes Available: A Cross-Sectional Study. Vaccines (Basel). 2021; 9(12). PMC: 8709027. DOI: 10.3390/vaccines9121398. View

4.
Li S, Hao J, Su Y, Zhan H, Zhou N, Qiu Y . COVID-19 vaccine hesitancy and influencing factors among Chinese hospital staff: a cross-sectional study. Sci Rep. 2024; 14(1):4369. PMC: 10883913. DOI: 10.1038/s41598-024-55001-z. View

5.
Beccia F, Lontano A, Rossi M, Marziali E, Pascucci D, Raponi M . Three-year COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: The threat of acceptance decline in seasonal campaigns. Hum Vaccin Immunother. 2023; 19(2):2252708. PMC: 10503443. DOI: 10.1080/21645515.2023.2252708. View